Debt ReductionThe successful completion of the Spine sale has significantly reduced net debt, strengthening the company's financial position.
Market PositioningThe company maintains a strong foothold in the premium implant market, suggesting robust competitive advantages and growth potential.
Profitability OutlookManagement has outlined a clear strategy to achieve a 15%+ adjusted EBITDA margin, signaling a strong potential for enhanced profitability.